PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
ENFN vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

ENFN vs. ABBV

Last updated Jun 4, 2026

ENFN (Enfusion, Inc.) and ABBV (AbbVie Inc.) are both stocks. ENFN operates in Software - Application (Technology), while ABBV operates in Drug Manufacturers - General (Healthcare).

Performance

ENFN vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enfusion, Inc. (ENFN) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

ENFN

1D
0.00%
1M
0.00%
YTD
—
6M
—
1Y
—
3Y*
—
5Y*
—
10Y*
—

ABBV

1D
0.80%
1M
4.31%
YTD
-3.41%
6M
-4.15%
1Y
19.73%
3Y*
20.88%
5Y*
18.44%
10Y*
17.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ENFN vs. ABBV - Yearly Performance Comparison

2026 (YTD)
ENFN
Enfusion, Inc.		0.00%
ABBV
AbbVie Inc.		-2.01%

Fundamentals

Total Revenue (TTM)

ENFN:

$201.61M

ABBV:

$62.82B

Gross Profit (TTM)

ENFN:

$136.74M

ABBV:

$46.15B

EBITDA (TTM)

ENFN:

$14.66M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Enfusion, Inc.

AbbVie Inc.

Often compared with ENFN:
ENFN vs. SMCIENFN vs. XLFENFN vs. CEGENFN vs. CALMENFN vs. CHSCLENFN vs. CMCSAENFN vs. LMT
Often compared with ABBV:
ABBV vs. JNJABBV vs. ABTABBV vs. LLYABBV vs. PFEABBV vs. MRKABBV vs. VOOABBV vs. AMGN

Return for Risk

ENFN vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
ENFN
ABBV
ABBV Risk / Return Rank: 6262
Overall Rank
ABBV Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6060
Sortino Ratio Rank
ABBV Omega Ratio Rank: 5959
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6363
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENFN vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enfusion, Inc. (ENFN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ENFN vs. ABBV - Sharpe Ratio Comparison

Loading charts...

Sharpe Ratios by Period

ENFNABBVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

—

0.83

—

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

—

0.81

—

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.68

—

Sharpe Ratio (All Time)

Calculated using the full available price history

—

0.73

—

Drawdowns

ENFN vs. ABBV - Drawdown Comparison

The maximum ENFN drawdown since its inception was 0.00%, smaller than the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ENFN and ABBV.

Loading charts...

Drawdown Indicators

ENFNABBVDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-45.09%

+45.09%

Max Drawdown (1Y)

Largest decline over 1 year

—

-17.32%

—

Max Drawdown (3Y)

Largest decline over 3 years

—

-20.74%

—

Max Drawdown (5Y)

Largest decline over 5 years

—

-21.92%

—

Max Drawdown (10Y)

Largest decline over 10 years

—

-45.09%

—

Current Drawdown

Current decline from peak

0.00%

-9.04%

+9.04%

Average Drawdown

Average peak-to-trough decline

0.00%

-10.73%

+10.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

—

7.69%

—

Volatility

ENFN vs. ABBV - Volatility Comparison

Loading charts...

Volatility by Period

ENFNABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

—

5.42%

—

Volatility (6M)

Calculated over the trailing 6-month period

—

17.61%

—

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

23.96%

-23.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

22.84%

-22.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

25.74%

-25.74%

Dividends

ENFN vs. ABBV - Dividend Comparison

ENFN has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.10%.

PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.		3.10%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
ENFN
Enfusion, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ENFN vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Enfusion, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.005.00B10.00B15.00B20222023202420252026
52.94M
15.00B
(ENFN) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for ENFN and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer